Unilever vs Estee Lauder Companies: why the prices moved differently

• ▲

  Strongest volume growth since 2010 lifts outlook Unilever reported its best quarterly volume growth in 16 years, with Q2 volumes up 5.5% and sales up 5.8%. Management raised full-year sales growth guidance to 4-6% from the bottom of that range. This shows customers are buying more products, not just paying higher prices, which is a healthier kind of growth and directly boosts profit expectations.

  This is the core new event that drove the stock's biggest jump in four years and answers why UNLYD is moving now.

• ▲

  Shares rally over 8% on results and guidance upgrade Unilever shares jumped more than 8% in London and US trading, the biggest daily gain in four years, after the strong results and raised outlook. The rally lifted the FTSE 100 and European consumer goods stocks. This price move reflects investors quickly repricing the company's growth prospects upward.

  It captures the immediate market reaction to the new earnings news, which is central to why the stock is moving right now.

• ▲

  UK regulator opens consultation on McCormick food deal The UK competition watchdog is inviting comments on McCormick's acquisition of Unilever's food business until August 5. The deal values the food arm at about $45 billion, with Unilever receiving $15.7 billion cash and a large stake in the combined company. Regulatory review is a normal step and does not block the value-unlocking sale.

  It is a new regulatory development in the ongoing food sale, which is a major driver of Unilever's transformation and share price.

• ▲

  Worker commitments agreed ahead of food sale completion Unilever agreed with European unions on job protections and consultation timelines for two years after the deal closes, expected by mid-2027. This removes a potential labor obstacle to the $44.8 billion sale. The deal will leave Unilever shareholders owning 55.1% of the enlarged group, with Unilever keeping a 9.9% stake and receiving $15.7 billion cash.

  It is a new step that de-risks the food sale, supporting the company's simplification and cash return story.

Based on 9 stories →

• ▲

  Unilever to sell food division for $45B Unilever agreed to merge its food business (Hellmann's, Knorr) with McCormick in a $45 billion deal, receiving about $15.7 billion in cash. This simplifies Unilever into a beauty and wellness company and returns cash to shareholders, which supports the share price.

  This is the biggest new event of the period and directly changes Unilever's business and finances.

• ◆

  Unilever eyes $4B Thorne supplements bid Unilever is exploring a $4 billion bid for Thorne, a fast-growing supplements brand. It fits the wellness push but is pricey, and past deals like Dollar Shave Club have disappointed. The market may worry about overpaying, so the effect is uncertain.

  This is a new potential acquisition that could shift Unilever's growth profile and capital allocation.

• ▲

  Record M&A backdrop boosts Unilever's deal Global M&A hit a record $2.6 trillion in the first half of 2026, and UK deal value is on track for a record year. Unilever's food sale is a top deal, and the strong market makes it more likely to complete on good terms.

  The broader deal boom increases confidence that Unilever's divestment will close successfully and at a good valuation.

• ▲

  Berkshire interest could ease deal financing Reports suggest Berkshire Hathaway, with nearly $400 billion in cash, could help finance McCormick's purchase of Unilever's food unit. That reduces the risk the deal stalls and supports the $45 billion valuation for Unilever's assets.

  A deep-pocketed backer lowers execution risk on the food sale, a key driver for Unilever's shares.

Based on 7 stories →

• ▲

  Goldman Sachs reinstates Buy, sees durable recovery Goldman Sachs reinstated coverage with a Buy rating and $100 target, saying investors underestimate the turnaround. It cited new leadership, the Beauty Reimagined strategy, and One ELC cost cuts that returned the company to growth after three down years. This boosts confidence and can pull the stock up.

  A major analyst endorsement directly supports the bull case and can attract buyers.

• ▼

  Restructuring charges rise to about $1.75 billion Estée Lauder now expects restructuring charges of roughly $1.75 billion, up from a prior $1.5–$1.7 billion range. The higher costs are tied to job cuts, digital upgrades, and office exits. This weighs on near-term profits and the stock, though the program should finish by fiscal 2027.

  Higher-than-expected restructuring costs are a real counterweight to the turnaround story.

• ▲

  Fiscal 2026 beat and strong 2027 guidance Estée Lauder beat fiscal 2026 targets, with organic sales up 3% and operating margin expanding 320 basis points to 11.2%. It guided fiscal 2027 EPS to $3.10–$3.35, above analyst estimates, and raised its operating margin outlook. This signals the turnaround is working and supports a higher stock price.

  The earnings beat and raised guidance are the core new fundamental drivers of the stock.

• ▲

  Luxury fragrance and China demand drive growth Strong demand for luxury fragrance and skincare, led by Le Labo and Tom Ford, drove 10% category sales growth. Mainland China delivered 9% organic growth with market share gains every quarter. This shows the company's key growth engines are firing, which can push the stock up.

  Demand strength in high-margin categories and China is a key reason the stock is moving higher.

Based on 6 stories →

• ▲

  Q4 earnings beat and turnaround progress Estée Lauder reported fiscal Q4 revenue of $3.63 billion and adjusted EPS of $0.39, beating expectations. Sales rose 6% organically, and operating margin improved sharply. Management pointed to market share gains in mainland China and growth across most categories, signaling that the turnaround under CEO Stéphane de La Faverie is gaining traction. The stock jumped over 16% on the news.

  This is the main new event that directly answers why EL moved, with strong positive impact.

• ▲

  Raised margin guidance and reaffirmed sales outlook The company reaffirmed its fiscal 2027 sales outlook and raised guidance for adjusted operating margin, a key profitability measure. This suggests management is confident in its cost-cutting and restructuring efforts, including the One ELC initiative and a net reduction of about 10,000 jobs. The improved profitability outlook supports a higher stock price.

  Guidance is a forward-looking driver that investors weigh heavily, and it reinforces the positive earnings surprise.

• ▼

  Data breach raises regulatory and reputational risks Estée Lauder disclosed a data security incident involving a vulnerability in Oracle's HR system, where an unauthorized party accessed personal information of some customers. The company notified law enforcement and added safeguards. While the financial impact is unclear, such breaches can lead to fines, lawsuits, and reputational damage, potentially weighing on the stock.

  This is a new negative event that could affect EL's price and is not yet reflected in the earnings-driven rally.

• ▼

  Intensifying competition in skincare from e.l.f. Beauty e.l.f. Beauty's skincare brands—e.l.f. SKIN, Naturium, and rhode—are gaining scale and market share, with combined retail sales exceeding $1 billion. This directly challenges Estée Lauder's prestige skincare portfolio, especially in mass and masstige channels. Continued share gains by e.l.f. could pressure Estée Lauder's sales growth and pricing power.

  This is a new competitive development that poses a risk to EL's market position and future growth.

Based on 9 stories →